Will Captopril significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017) | Manifold

Will Captopril significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)

Plus

10

Ṁ82

2032

32%

chance

1D

1W

1M

ALL

...treatments that can decelerate the rate of aging are the only available path to significantly increase human lifespan going forward. Before drugs and treatments can be considered for larger clinical studies in humans, pilot trials in rodents must be performed as a necessary prerequisite. This is why the National Institute on Aging established the Interventions Testing Program which “is a multi-institutional study investigating treatments with the potential to extend lifespan and delay disease and dysfunction in mice”. So far it is the largest systematic effort to test potentially life-extending compounds in mice that has been performed. This is an attempt to give the biogerontology community, interested experts and laypeople an opportunity to predict outcomes of this important experiment. See also: http://biogerontolgy.blogspot.com/2022/02/a-prediction-market-for-nias-mouse.html

This question is managed and resolved by Manifold.

#Ancient Markets

#Please Resolve

Get

1,000

and

3.00

Sort by:

Do we know the correct resolution for this market?

predictedNO

Recommended resolution: No.

See tables 2 & 3 here: https://onlinelibrary.wiley.com/doi/10.1111/acel.13724.

predictedNO

@StephenMalina should have said table 1...

Related questions

Will 1,3-butanediol significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)

By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?

Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?

Will a senolytic drug be used clinically to slow, prevent, or reverse aging by the end of 2033?

Will Altos Labs trial an anti-aging intervention in humans by 2030?

Will the Robust Mouse Rejuvenation Study by the LEVF succeed in increasing mouse lifespan 12 months?

Will Aubrey de Grey's 2022 Robust Mouse Rejuvenation Project "succeed" in its aims of finding an intervention that increases both mean and maximum lifespan of mice by at least 12 months?

Will any molecule be shown to extend longevity in the ITP program in 2024?

Will a study show that the combination of parabiosis + genetic reprogramming will improve lifespan more than either intervention alone by 2035?

By which year will longevity research enable a pet cat's lifespan to be extended by 10 years?

Related questions

Will 1,3-butanediol significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)

Will the Robust Mouse Rejuvenation Study by the LEVF succeed in increasing mouse lifespan 12 months?

By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?

Will Aubrey de Grey's 2022 Robust Mouse Rejuvenation Project "succeed" in its aims of finding an intervention that increases both mean and maximum lifespan of mice by at least 12 months?

Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?

Will any molecule be shown to extend longevity in the ITP program in 2024?

Will a senolytic drug be used clinically to slow, prevent, or reverse aging by the end of 2033?

Will a study show that the combination of parabiosis + genetic reprogramming will improve lifespan more than either intervention alone by 2035?

Will Altos Labs trial an anti-aging intervention in humans by 2030?

By which year will longevity research enable a pet cat's lifespan to be extended by 10 years?

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules